- About us
- Value, Pricing & Access
- Medical & Scientific Affairs
- Centers of Excellence
- Join Putnam
Prepare for lasting clinical and commercial success when you build and optimize your product and portfolio value with us. Science-based, future-focused, and comprehensive, our strategies provide sound guidance for your most critical clinical development, opportunity prioritization, and go/no-go decisions.
With a unique blend of clinical and scientific expertise, innovative business strategy, and more than three decades of strategic experience, we advise on optimal and sustainable pharmaceutical portfolio analysis and diligence and early pipeline strategies.
Rooted in a strong understanding of the science and evolving market, we can help your cross–functional teams understand where to position their early–stage assets and platforms in the future landscape, and how to optimize their clinical development path and maximize the asset value.
We can help you with:
Get the latest insights and perspectives from our experts.
Putnam is pleased to announce the addition of Stephen McGarry to the team. Steve started with Putnam in June 2023 as a...
With several other in-class competitors, a client sought Putnam’s guidance on a go/no-go development decision for a first-generation targeted...
A clinical-stage biopharmaceutical company sought to develop an optimized portfolio strategy. It sought Putnam’s guidance to prioritize asset-level...